Latest Product Launches News

AFT Pharmaceuticals has received tentative US FDA approval for its Scomara cream to treat Facial Angiofibromas in Tuberous Sclerosis, but US commercialisation is postponed until 2029 due to orphan drug exclusivity. The approval bolsters regulatory prospects in other key markets where AFT anticipates competitive advantages.

HUB24 delivered a standout FY26 with record net inflows of $18.9 billion, a 20% rise excluding large migrations, and boosted total Funds Under Administration to $164.3 billion. The platform’s adviser base grew 11%, while new product launches and AI-driven tools expanded its market footprint.

Gratifii Limited has executed a binding agreement to acquire Mosh, with settlement imminent, while deferring completion of its Simplicity acquisition to early 2027 under revised, earnings-linked terms.

AnteoTech has secured independent validation for its Ultranode™ 95 silicon anode in commercial drone battery cells, launched a new battery additive, and strengthened its cash position with a A$10 million capital raise.

Norwood Systems lifted FY26 customer cash receipts to a record A$2.327 million, driven by multiple Tier-1 carrier contracts and successful AI pilot completions in Australia and the UK.

ECS Botanics delivered a fourth consecutive quarter of positive operating cash flow in Q4 FY26, with a full-year turnaround of $5.9 million. The company’s branded B2C revenue surged 31% year-on-year, supported by product launches and European market expansion.

Microba Life Sciences has delivered robust FY26 growth in its core microbiome testing business, with revenues up 92% year-on-year and a new GI Navigator product set for launch in September 2026. The company also announced a $7 million annualised cost reduction program as it advances towards cashflow break-even.

Activeport’s Global Edge platform has secured contracts with Spark and ViewQwest, setting the stage for a significant uplift in recurring revenue and international expansion.

Datagate Innovation Limited reports steady 23% ARR growth despite customer churn and pricing pressure, while targeting a US$5 million ARR milestone to enhance its valuation over the next two years.

ReNerve has locked in a flexible A$5 million convertible note facility with RiverFort, drawing an initial A$1.6 million to back its commercial push and US sales ramp-up.

SPC Global reported solid Q4 FY26 growth driven by domestic beverage sales and a 50.8% jump in international revenue, while a $100 million equity raise slashed net leverage and paved the way for improved cash flow in FY27.

Atomos Limited has trimmed its FY26 sales guidance to approximately $40 million due to softer end-consumer demand and delayed product shipments, while forecasting EBITDA between $2.5 million and $3.5 million supported by improved margins.